Change of Adviser

RNS Number : 8187C
Chesterfield Resources PLC
20 June 2019
 

Chesterfield Resources / EPIC: CHF / Market: LSE / Sector: Mining

 

20 June 2019

 

Chesterfield Resources Plc ( 'Chesterfield' or the 'Company')

 

Chesterfield Resources appoints Brandon Hill Capital as Broker

 

Chesterfield Resources Plc, a copper exploration company focussed in Cyprus, is pleased to announce that it has appointed Brandon Hill Capital as its Broker, effectively immediately. Brandon Hill Capital will be advising the company on its growth strategy, including corporate development and messaging.

Martin French, Executive Chairman stated "We are delighted to welcome Brandon Hill to our stakeholders family. The appointment is part of a wider programme to raise the company's profile in the market. In line with this, we will soon be launching a new website and corporate presentation. Chesterfield is developing a strategy to grow the company and shareholder value."

 

About Chesterfield Resources Plc

Chesterfield Resources is a copper-gold exploration and development Company active in Cyprus. The Company generates value for shareholders by discovering and developing multiple deposits to production. Chesterfield is currently progressing its Cyprus Project.

Market Abuse Regulation (MAR) Disclosure

Certain information contained in this announcement would have been deemed inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 until the release of this announcement.

 

 

**ENDS**

 For further information, please visit www.chesterfieldresourcesplc.com or contact:

 

Chesterfield Resources plc:

Martin French, Executive Chairman                                     Tel: +44 (0)7901 552277

 

Brandon Hill Capital (Broker):

Jonathan Evans/Oliver Stansfield                                              Tel:  +44 20 3463 5000

 

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
APPKMGMVVLGGLZM
UK 100